reports
Synaptics Showcases Edge AI Innovations at CES 2026
Synaptics Showcases Edge AI Innovations at CES 2026 Featuring Synaptics Astra™, Veros™, and Multimodal Sensing SAN JOSE, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced that it will showcase a broad portfolio of AI-native processing, sensing, and connectivity technologies at CES 2026. These solutions demonstrate how intelligence at the Edge transforms real-world applications across consumer, industrial, smart home, and enterprise markets.As global demand grows for devices that can interpret their environment, make context-aware decisions, and...
Synaptics Inc: 1 director
A director at Synaptics Inc sold 18,285 shares at 80.291USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
KALA BIO Announces Closing of $10 Million Registered Direct Offering o...
KALA BIO Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules ARLINGTON, Mass., Dec. 05, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant in lieu thereof). H.C. Wainwright & Co. acted as the exclusi...
Appian Corporation to Present at the Barclays 23rd Annual Global Techn...
Appian Corporation to Present at the Barclays 23rd Annual Global Technology Conference MCLEAN, Va., Dec. 04, 2025 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN), today announced that Serge Tanjga, Chief Financial Officer, will present at the Barclays 23rd Annual Global Technology Conference in San Francisco, CA. The fireside chat is scheduled for Wednesday, December 10, 2025 at 8:40am Pacific Time and will be webcast live at the following link: Replays of the fireside chat will be available for a limited time under the “News and Events” section of the Company’s investor relations website at ...
KALA BIO Announces $10 Million Registered Direct Offering of Common St...
KALA BIO Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules ARLINGTON, Mass., Dec. 04, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA) (“KALA” or the “Company”), today announced that it has entered into definitive agreements for the purchase of an aggregate of 10,000,000 shares of its common stock (or pre-funded warrants in lieu thereof), at a purchase price of $1.00 per share (or pre-funded warrant in lieu thereof) in a registered direct offering priced at-the-market under Nasdaq rules. The closing of the offering is expected to...
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Inv...
KALA BIO Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar Investment to support the continued evaluation and redevelopment of KALA’s product candidates and patent portfolio, and provide working capital and funding for a potential future strategic transaction ARLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, announces it has entered into a $6 million securit...
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, ...
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, December 2, 2025 and Wednesday, December 10, 2025 SAN JOSE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in upcoming investor conferences. Rahul Patel, President and Chief Executive Officer, will participate in UBS’ Global Technology and AI Conference 2025 on Tuesday, December 2, 2025Rahul Patel, President and Chief Executive Officer, and Ken Rizvi, CFO, will present at Barclays 23rd Annual Global Technology Conference on Wednesday, December 10, 2025 at ...
Synaptics to Participate at Upcoming Investor Conference Wednesday, No...
Synaptics to Participate at Upcoming Investor Conference Wednesday, November 19, 2025 SAN JOSE, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced its participation in the upcoming investor conference. Ken Rizvi, Chief Financial Officer, will present at the Wells Fargo 9th Annual TMT Summit on Wednesday, November 19, 2025, at 1:30 PM PT. To view the webcast or access a replay, please visit About Synaptics Incorporated: Synaptics (Nasdaq: ) is driving innovation in AI at the Edge, bringing AI closer to end users and transforming how we engage wi...
Synaptics and Qualcomm Partner to Advance Fingerprint and Touch Techno...
Synaptics and Qualcomm Partner to Advance Fingerprint and Touch Technology Across PC and Mobile Platforms Combining ecosystem expertise with advanced human-interface and sensing technologies, the engagement focuses on amplifying security and performance across AI PC and mobile platforms SAN JOSE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) and Qualcomm Technologies, Inc. have entered into a strategic engagement to focus on advancing Touch and Fingerprint Sensor Technology across the mobile and compute industry. By partnering, both companies expect to fur...
Synaptics Reports First Quarter Fiscal 2026 Results
Synaptics Reports First Quarter Fiscal 2026 Results Launched the next-generation of Astra multimodal GenAI processors to power the intelligent IoT edge Core IoT product sales increased 74 percent year-over-year Q1'26 Financial Results Revenue of $292.5 million, up 14% year-over-yearFiscal first quarter Core IoT product sales grew by 74% year-over-yearGAAP gross margin of 42.6%Non-GAAP gross margin of 53.2%GAAP loss per share of $0.53Non-GAAP diluted earnings per share of $1.09 SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Synaptics Incorporated (Nasdaq: ) today reported financi...
Appian Announces Third Quarter 2025 Financial Results
Appian Announces Third Quarter 2025 Financial Results Third quarter cloud subscriptions revenue increased 21% year-over-year to $113.6 millionThird quarter total revenue increased 21% year-over-year to $187.0 million MCLEAN, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights: Revenue: Cloud subscriptions revenue was $113.6 million, up 21% compared to the third quarter of 2024. Total subscriptions revenue, which includes sales of our cloud subscriptio...
Amicus Therapeutics Announces Third Quarter 2025 Financial Results an...
Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates Q3 2025 Total Revenue of $169M, up 17% at CER Positive Q3 2025 GAAP Net Income of $17M Cash Position of $264M, a $33M Increase in Q3 2025 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the quarter ended September 30, 2025. “Amicus achieved yet another impressive qu...
Amicus Therapeutics to Present at Upcoming Investor Conferences in Nov...
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November. 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ETJefferies Global Healthcare Conference 2025 in London, U.K. on Tuesday, November 18, 2025, at 4:30 p.m. GMT A live audio webcast of each presentation can also be accessed via the investors se...
Kala Bio Inc: 5 directors
Five Directors at Kala Bio Inc sold 303,413 shares at between 0.810USD and 0.830USD. The significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the las...
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results o...
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss financial results for the quarter ended September 30, 2025. Participants and investors interested in accessing the call by phone will need to register using the . After registering, all phone participants will receive a dial-in number along with a personal PIN to access the eve...
- Jonathan Moreland
VIRC VIRCO MANUFACTURING CORP.
THFF FIRST FINANCIAL CORP. (INDIANA)
SSNC SS&C TECHNOLOGIES HOLDINGS INC.
SPWH SPORTMANS WAREHOUSE HOLDINGS
PSEC PROSPECT CAPITAL CORPORATION
FDS FACTSET RESEARCH SYSTEMS INC.
CAPL CROSSAMERICA PARTNERS LP
CALM CAL-MAINE FOODS INC.
CAG CONAGRA BRANDS INC.
ANGO ANGIODYNAMICS INC.
ASA ASA
ADC AGREE REALTY CORPORATION
RIGN TRANSOCEAN LTD.
RVP RETRACTABLE TECHNOLOGIES INC.
TRT TRIO TECH INTERNATIONAL
FSFG FIRST SAVINGS FINANCIAL GROUP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
AMBC AMBAC FINANCIAL GROUP INC.
GWRS GLOBAL WATER RESOURCES
BRT BRT APARTMENTS
ZIVO ZIVO BIOSCIENCE
CPSH INC.
FUND CPS TECHNOLOGIES
FGBI ROYCE FOCUS TRUST
STRO INC.
SAVA FIRST GUARANTY BANCSHARES
DX SUTRO BIOPHARMA
PNTG CASSAVA SCIENCES
PCB DYNEX CAPITAL INC.
WWR PENNANT GROUP
ACET PACIFIC CITY FINANCIAL CORP
ALTM WESTWATER RESOURCES
CGEM ADICET BIO INC
OPEN ALTUS MIDSTREAM COMPANY (A)
GGZ CULLINAN ONCOLOGY INC
IMRX OPENDOOR TECHNOLOGIES INC.
REFI GABELLI GLOBAL SMALL AND MID CAP VALUE TRUST
PEPG IMMUNEERING CORP
VANI CHICAGO ATLANTIC REAL ESTATE FINANCE INC
UAMY PEPGEN INC
SOC VIVANI MEDICAL INC
LAW U S ANTIMONY CORP
MRAI SABLE OFFSHORE CORP
HYMC CS DISCO INC
SABS MARPAI
INC.
HYCROFT MINING HOLDING CORPORATION
BIG CYPRESS ACQUISITION CORP.
Synaptics to Report First Quarter Fiscal 2026 Results on November 6, 2...
Synaptics to Report First Quarter Fiscal 2026 Results on November 6, 2025 SAN JOSE, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) today announced that it will report financial results for the first quarter of fiscal 2026 on Thursday, November 6, 2025, after the market closes. The Company will host a corresponding conference call for analysts and investors at 2:00 p.m. PT (5:00 p.m. ET), to discuss the results. To participate on the live call, analysts and investors should pre-register at . Registrants will receive dial-in information and a unique passcode ...
Appian To Announce Third Quarter 2025 Financial Results on November 6,...
Appian To Announce Third Quarter 2025 Financial Results on November 6, 2025 MCLEAN, Va., Oct. 15, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: APPN) today announced that it will release financial results for the third quarter ended September 30, 2025 before the U.S. financial markets open on Thursday, November 6, 2025. The company will host a conference call and live webcast to review its financial results and business outlook. Conference Call Details The conference call will begin at 8:30 a.m. Eastern Time. To access the call, please use this . Once registered, participants can join the call, us...
Synaptics Launches the Next Generation of Astra™ Multimodal GenAI Proc...
Synaptics Launches the Next Generation of Astra™ Multimodal GenAI Processors to Power the Future of the Intelligent IoT Edge SAN JOSE, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: ) announces the new Astra™ SL2600 Series of multimodal Edge AI processors designed to deliver exceptional power and performance. The Astra SL2600 series enables a new generation of cost-effective intelligent devices that make the cognitive Internet of Things (IoT) possible. The SL2600 Series will launch with the , featuring five processor families tailored for diverse Edge AI appli...
- Jonathan Moreland
WOR WORTHINGTON INDUSTRIES INC.
SPWH SPORTMANS WAREHOUSE HOLDINGS
PSEC PROSPECT CAPITAL CORPORATION
FDS FACTSET RESEARCH SYSTEMS INC.
CALM CAL-MAINE FOODS INC.
CAG CONAGRA BRANDS INC.
ANGO ANGIODYNAMICS INC.
KRNY KEARNY FINANCIAL CORP.
ADC AGREE REALTY CORPORATION
CULP CULP INC.
RIGN TRANSOCEAN LTD.
RVP RETRACTABLE TECHNOLOGIES INC.
FSFG FIRST SAVINGS FINANCIAL GROUP INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
AMBC AMBAC FINANCIAL GROUP INC.
HAIN THE HAIN CELESTIAL GROUP
GWRS INC.
AROC GLOBAL WATER RESOURCES
ZIVO ARCHROCK INC.
CPSH ZIVO BIOSCIENCE
FUND INC.
ARVN CPS TECHNOLOGIES
FGBI ROYCE FOCUS TRUST
BCDA INC.
SAVA ARVINAS HOLDING
DX FIRST GUARANTY BANCSHARES
AOUT BIOCARDIA
ACET CASSAVA SCIENCES
ALTM DYNEX CAPITAL INC.
CGEM AMERICAN OUTDOOR BRANDS
OPEN INC.
GGZ ADICET BIO INC
IMRX ALTUS MIDSTREAM COMPANY (A)
ABSI CULLINAN ONCOLOGY INC
PEPG OPENDOOR TECHNOLOGIES INC.
MRVL GABELLI GLOBAL SMALL AND MID CAP VALUE TRUST
UAMY IMMUNEERING CORP
PRAX ABSCI CORP
LAW PEPGEN INC
MRAI MARVEL BIOSCIENCES CORP
JSPR U S ANTIMONY CORP
BDSX PRAXIS PRECISION MEDICINES INC
SABS CS DISCO INC
MARPAI
INC.
AMPLITUDE HEALTHCARE ACQUISITION CORP
BIODESIX INC
BIG CYPRESS ACQUISITION CORP.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.